Regeneron Pharmaceuticals is paying $250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. The biotech's lead drug candidate is currently in pivotal testing in melanoma.
Unlearn.AI's Series B round follows a positive European Medicines Agency draft opinion finding that the company's artificial intelligence technology can be used in Phase 2 and Phase 3 clinical trials. The startup is now on the hunt for pharmaceutical partners that want to use this "digital twin" technology to speed up their clinical research.
By Waqaas Al-Siddiq Tuesday, April 19, 2022 4:59 PM
The traditional fee-for-service arrangements have caused misaligned incentives across the board for patients, physicians, and payers – and proved a huge obstacle to improving care. Recognizing this gap, CMS began to facilitate a shift towards outcome-based care by focusing on outpatient monitoring and disease management. This has led to progress in adopting new reimbursement models.
By Michael Schroeder Tuesday, April 19, 2022 1:00 PM
The program, called Digital Bridge, will leverage Icario's expertise in personalized health communications to help plans ensure members are able to access resources available to get low-cost or free broadband.
By Vikram Chaudhery Tuesday, April 19, 2022 12:47 PM
Scaling too soon or too fast can kill your growing business. That's why you need to understand the industry dynamics, have the right core team, and put a plan in place to take your company to the next level.
No comments